Back to Directory
Last Updated: 03/06/2026
Synexa Life Sciences
Manchester
Founded 2003
Specialist biomarker and bioanalytical CRO for clinical drug development
Synexa Life Sciences is a specialist contract research organisation providing biomarker and bioanalytical laboratory services to global biopharmaceutical companies.
The company develops, validates, and delivers custom assays supporting clinical trials and translational studies, with expertise spanning LC-MS/MS bioanalysis, immunoassays, flow cytometry, ELISpot, and genomic services.
The UK laboratory in Manchester operates alongside global sites in Cape Town and Turku. Synexa is backed by Gilde Healthcare and acquired Alderley Analytical in 2024.